<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00622453</url>
  </required_header>
  <id_info>
    <org_study_id>9609-31</org_study_id>
    <nct_id>NCT00622453</nct_id>
  </id_info>
  <brief_title>Arrhythmias in Myotonic Muscular Dystrophy</brief_title>
  <acronym>DM1</acronym>
  <official_title>A Registry of Arrhythmias in Myotonic Muscular Dystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Muscular Dystrophy Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adult myotonic muscular dystrophy (Steinert's disease) is the most common inherited
      neuromuscular disorder. Cardiac rhythm disturbances occur frequently in this disease state
      and may be responsible for up to one-third of deaths. In this study, we intend to evaluate
      the utility of non-invasive electrocardiographic screening methods and history in predicting
      serious arrhythmic events.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The long term objectives of this population study is a more defined natural history, optimal
      diagnostic testing methodology, and methods of therapy for arrhythmias in individuals with
      myotonic muscular dystrophy. The goal is a more adequate definition of appropriate diagnosis
      and therapy for arrhythmias in order to decrease the likelihood of cardiac morbidity and
      mortality in this disorder.

      The specific aims of the study involve an initial survey of individuals with myotonic
      muscular dystrophy detailing multiple factors. Non-invasive electrocardiographic testing will
      be done. Using this initial data and subsequent follow-up data collected yearly the cohort of
      patients will be followed as to arrhythmia development over a minimum of five years and
      likely longer with a long-term registry and evaluation of National Death Records and
      Ancestry.com. This project is unique in that it characterizes a non-neurologic abnormality
      associated with a neuromuscular disease, myotonic muscular dystrophy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 1996</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">January 2006</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate incidence of arrhythmias in myotonic muscular dystrophy</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate with diagnostic non-invasive electrocardiogram (ECG)</measure>
    <time_frame>3 Years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">448</enrollment>
  <condition>Muscular Dystrophy</condition>
  <condition>Arrhythmia</condition>
  <condition>Sudden Cardiac Death</condition>
  <arm_group>
    <arm_group_label>Registry of Arrhythmias</arm_group_label>
    <description>Screening of individuals with myotonic muscular dystrophy to evaluate the utility of non-invasive electrocardiographic screening methods and history in predicting serious arrhythmic events.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Screening</intervention_name>
    <description>Electrocardiography Blood Test</description>
    <arm_group_label>Registry of Arrhythmias</arm_group_label>
    <other_name>ECG</other_name>
    <other_name>Holter Monitor</other_name>
    <other_name>Blood Test</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient Recruitment: Will take place at the 230 hospital-affiliated MDA neuromuscular
        clinics. Individuals with myotonic dystrophy will be identified in the MDA clinics these
        will be asked to participate in the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 and over

          2. Willing to sign informed consent

          3. Have a previous diagnosis of myotonic muscular dystrophy

        Exclusion Criteria:

          1. Under age 18.

          2. Unwilling to sign consent.

          3. Unwilling to commit to long-term follow-up.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William Groh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Krannert Institute of Cardiology</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, Pourmand R, Otten RF, Bhakta D, Nair GV, Marashdeh MM, Zipes DP, Pascuzzi RM. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med. 2008 Jun 19;358(25):2688-97. doi: 10.1056/NEJMoa062800.</citation>
    <PMID>18565861</PMID>
  </results_reference>
  <results_reference>
    <citation>Bhakta D, Lowe MR, Groh WJ. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J. 2004 Feb;147(2):224-7.</citation>
    <PMID>14760317</PMID>
  </results_reference>
  <results_reference>
    <citation>Hardin BA, Lowe MR, Bhakta D, Groh WJ. Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1. Ann Noninvasive Electrocardiol. 2003 Jul;8(3):227-32.</citation>
    <PMID>14510658</PMID>
  </results_reference>
  <results_reference>
    <citation>Groh WJ, Lowe MR, Zipes DP. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol. 2002 May;13(5):444-8.</citation>
    <PMID>12030525</PMID>
  </results_reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2008</study_first_submitted>
  <study_first_submitted_qc>February 13, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2008</study_first_posted>
  <last_update_submitted>February 13, 2018</last_update_submitted>
  <last_update_submitted_qc>February 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 14, 2018</last_update_posted>
  <responsible_party>
    <name_title>William Groh, MD</name_title>
    <organization>Indiana University</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Death</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Myotonic Dystrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

